Leukemia and Lymphoma in Pregnancy

Hematology/Oncology Clinics of North America

Volumn 25, Issue 2, 2011, Pages 277-291

  Abadi, Uri ^a   Koren, Gideon ^b,c   Lishner, Michael ^a,d  

^a MEIR MEDICAL CENTER   (Israel)

^b UNIVERSITY OF TORONTO   (Canada)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

^d TEL AVIV UNIVERSITY   (Israel)

Author keywords

Chemotherapy; Fetus; Leukemia; Lymphoma; Malformations; Pregnancy

Indexed keywords

AMINOGLYCOSIDE; AMOXICILLIN; AMPHOTERICIN B; ANTINEOPLASTIC AGENT; BLEOMYCIN; CEPHALOSPORIN; CHLORAMBUCIL; CLARITHROMYCIN; CYCLOPHOSPHAMIDE; CYTARABINE; CYTOTOXIC AGENT; DACARBAZINE; DAUNORUBICIN; DOXORUBICIN; ETOPOSIDE; FLUCONAZOLE; FLUDARABINE; IDARUBICIN; IMATINIB; METHOTREXATE; METRONIDAZOLE; OMEPRAZOLE; PENICILLIN G; PREDNISONE; PROCARBAZINE; RITUXIMAB; UNINDEXED DRUG; VINBLASTINE; VINCRISTINE; VORICONAZOLE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADVANCED CANCER; ADVERSE OUTCOME; AGGRESSIVE NK CELL LEUKEMIA; ALLOGENEIC STEM CELL TRANSPLANTATION; AMNION FLUID; BLOOD PLACENTA BARRIER; BONE MARROW BIOPSY; BONE MARROW SUPPRESSION; BURKITT LYMPHOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CARDIOTOXICITY; CESAREAN SECTION; CHILDHOOD CANCER; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; COLITIS; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONGENITAL HEART MALFORMATION; CONGENITAL MALFORMATION; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG DOSE ESCALATION; DRUG FATALITY; DRUG MEGADOSE; DRUG SAFETY; DRUG WITHDRAWAL; ECHOGRAPHY; FETUS ECHOGRAPHY; FETUS MALFORMATION; FETUS OUTCOME; FIRST TRIMESTER PREGNANCY; FOLLICULAR LYMPHOMA; FOLLOW UP; GENETIC VARIABILITY; HELICOBACTER INFECTION; HODGKIN DISEASE; HUMAN; HYDROCEPHALUS; HYPOSPADIAS; INFERTILITY; INTRAUTERINE GROWTH RETARDATION; KIDNEY CLEARANCE; KIDNEY MALFORMATION; LARGE CELL LYMPHOMA; LEUKAPHERESIS; LEUKEMIA; LEUKOPENIA; LIVER METABOLISM; LOW BIRTH WEIGHT; LYMPH NODE BIOPSY; LYMPHATIC LEUKEMIA; LYMPHOBLASTOMA; LYMPHOCYTOMA; LYMPHOMA; MANTLE CELL LYMPHOMA; MARGINAL ZONE LYMPHOMA; MUCOSA INFLAMMATION; MYCOSIS; NEUTROPENIA; NONHODGKIN LYMPHOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; ORGANOGENESIS; PHILADELPHIA CHROMOSOME POSITIVE CELL; PLASMA VOLUME; PREGNANCY; PREGNANCY TERMINATION; PREGNANT WOMAN; PREMATURE LABOR; PRENATAL EXPOSURE; PRIORITY JOURNAL; PROGNOSIS; PROMYELOCYTIC LEUKEMIA; PYLORUS STENOSIS; REMISSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; RISK MANAGEMENT; SECOND TRIMESTER PREGNANCY; SIDE EFFECT; SKELETON MALFORMATION; SPONTANEOUS ABORTION; STILLBIRTH; SURVIVAL RATE; T CELL LYMPHOMA; TERATOGENICITY; THIRD TRIMESTER PREGNANCY; THORAX RADIOGRAPHY; TREATMENT PLANNING; TUMOR LYSIS SYNDROME; UMBILICAL HERNIA;

AGE FACTORS; FEMALE; HUMANS; INCIDENCE; LEUKEMIA; LYMPHOMA; MALE; MATERNAL-FETAL EXCHANGE; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PREGNANCY COMPLICATIONS, NEOPLASTIC;

EID: 79953051831     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hoc.2011.01.001     Document Type: Review

References (51)

1. Pentheroudakis G., Pavlidis N. Cancer and pregnancy: poena magna, not anymore. Eur J Cancer 2006, 42:126-140.
2. The Motherisk guide to cancer in pregnancy and lactation 2005, Motherisk Program, Toronto. 2nd edition. G. Koren, M. Lishner, S. Santiago (Eds.).
3. Pavlidis N.A. Coexistence of pregnancy and malignancy. Oncologist 2002, 7:279-287.
4. Cohen-Kerem R., Railton C., Oren D., et al. Pregnancy outcome following non-obstetric surgical intervention. Am J Surg 2005, 190:467-473.
5. Pereg D., Lishner M. Maternal and fetal effects of systemic therapy in the pregnant woman with cancer. Cancer and pregnancy 2008, 21-38. Springer, Berlin. 1st edition. A. Surbone, F. Peccatori, N. Pavilidis (Eds.).
6. Cardonick E., Iacobucci A. Use of chemotherapy during human pregnancy. Lancet Oncol 2004, 5:283-291.
7. Weisz B., Meirow D., Schiff E., et al. Impact and treatment of cancer during pregnancy. Expert Rev Anticancer Ther 2004, 4:889-902.
8. Zemlickis D., Lishner M., Erlich R., et al. Teratogenicity and carcinogenicity in a twin exposed in utero to cyclophosphamide. Teratog Carcinog Mutagen 1993, 13:139-143.
9. Doll D.C., Ringenberg Q.S., Yarbro J.W. Management of cancer during pregnancy. Arch Intern Med 1998, 148:2058-2064.
10. Randall T. National registry seeks scarce data on pregnancy outcomes during chemotherapy. JAMA 1993, 269:323.
11. Leslie K.K., Koil C., Rayburn W.F. Chemotherapeutic drugs in pregnancy. Obstet Gynecol Clin North Am 2005, 32:627-640.
12. Zemlickis D., Lishner M., Degendorfer P., et al. Fetal outcome after in utero exposure to cancer chemotherapy. Arch Intern Med 1992, 152:573-576.
13. Aviles A., Neri N. Hematological malignancies and pregnancy: a final report of 84 children who received chemotherapy in utero. Clin Lymphoma 2001, 2:173-177.
14. Nulman I., Laslo D., Fried S., et al. Neurodevelopment of children exposed in utero to treatment of maternal malignancy. Br J Cancer 2001, 85:1611-1618.
15. Streffer C., Shore R., Konermann G., et al. Biological effects after prenatal irradiation (embryo and fetus). A report of the International Commission on Radiological Protection. Ann ICRP 2003, 33:205-206.
16. Otake M., Schull W.J. Radiation-related brain damage and growth retardation among the prenatally exposed atomic bomb survivors. Int J Radiat Biol 1998, 74:159-171.
17. Pereg D., Koren G., Lishner M. The treatment of Hodgkin's and non-Hodgkin's lymphoma in pregnancy. Hematologica 2007, 92:1230-1237.
18. Azim H.A., Pavlidis N., Peccatori F.A. Treatment of the pregnant mother with cancer: a systematic review on the use of cytotoxic, endocrine, targeted agents and immunotherapy during pregnancy. Part II: hematological tumors. Cancer Treat Rev 2010, 36:110-121.
19. Lishner M., Zemlickis D., Degendorfer P., et al. Maternal and foetal outcome following Hodgkin's disease in pregnancy. Br J Cancer 1992, 65:114-117.
20. Fenig E., Mishaeli M., Kalish Y., et al. Pregnancy and radiation. Cancer Treat Rev 2001, 27:1-7.
21. Connors J.M. Hodgkin's lymphoma clinical challenges. Challenging problems: coincident pregnancy, HIV Infection, and older age. Hematology Am Soc Hematol Educ Program 2008, 334-339.
22. Lambert J., Wijermans P.W., Dekker G.A., et al. Chemotherapy in non-Hodgkin's lymphoma during pregnancy. Neth J Med 1991, 38:80-85.
23. Garcia L., Valcarcel M., Santiago-Borrero P.J. Chemotherapy during pregnancy and its effects on the fetus-neonatal myelosuppression: two case reports. J Perinatol 1999, 19:230-233.
24. Ojeda-Uribe M., Gilliot C., Jung G., et al. Administration of rituximab during the first trimester of pregnancy without consequences for the newborn. J Perinatol 2006, 26:252-255.
25. Kimby E., Sverrisdottir A., Elinder G. Safety of rituximab therapy during the first trimester of pregnancy: a case history. Eur J Haematol 2004, 72:292-295.
26. Decker M., Rothermundt C., Hollander G., et al. Rituximab plus CHOP for treatment of diffuse large B-cell lymphoma during second trimester of pregnancy. Lancet Oncol 2006, 7:693-694.
27. Diav-Citrin O., Arnon J., Shechtman S., et al. The safety of proton pump inhibitors in pregnancy: a multicentre prospective controlled study. Aliment Pharmacol Ther 2005, 21:269-275.
28. Einarson A., Shuhaiber S., Koren G. Effects of antibacterials on the unborn child: what is known and how should this influence prescribing. Paediatr Drugs 2001, 3:803-816.
29. Lishner M., Zemlickis D., Sutcliffe S.B., et al. Non-Hodgkin's lymphoma and pregnancy. Leuk Lymphoma 1994, 14:411-413.
30. Berry D.L., Theriault R.L., Holmes F.A., et al. Management of breast cancer during pregnancy using a standardized protocol. J Clin Oncol 1999, 17:855-861.
31. Peterson C., Darrell R.L., Sanger W. Burkitt's lymphoma in early pregnancy. J Clin Oncol 2010, 28:e136-e138.
32. Lam M.S. Treatment of Burkitt's lymphoma during pregnancy. Ann Pharmacother 2006, 40:2048-2052.
33. Shapira T., Pereg D., Lishner M. How I treat acute and chronic leukemia in pregnancy. Blood Rev 2008, 22:247-259.
34. Reynoso E.E., Shepherd F.A., Messner H.A., et al. Acute leukemia during pregnancy: the Toronto Leukemia Study Group experience with long-term follow-up of children exposed in utero to chemotherapeutic agents. J Clin Oncol 1987, 5:1098-1106.
35. Greenlund L.J., Letendre L., Tefferi A. Acute leukemia during pregnancy. A single institutional experience with 17 cases. Leuk Lymphoma 2001, 41:571-577.
36. Chelghoum Y., Vey N., Raffoux E., et al. Acute leukemia during pregnancy: a report on 37 patients and a review of the literature. Cancer 2005, 104:110-117.
37. Schafer A.I. Teratogenic effects of antileukemic chemotherapy. Arch Intern Med 1981, 141:514-515.
38. Aviles A., Neri N., Nambo M.J. Long term evaluation of cardiac function in children who received anthracyclines during pregnancy. Ann Oncol 2006, 17:286-288.
39. Germann N., Goffiner F., Godwasser F. Anthracyclines during pregnancy: embryo-fetal outcome in 160 patients. Ann Oncol 2004, 15:146-150.
40. King C.T., Rogers P.D., Cleary J.D., et al. Antifungal therapy during pregnancy. Clin Infect Dis 1998, 27:1151-1160.
41. Sobel J.D. Use of antifungal drugs in pregnancy: a focus on safety. Drug Saf 2000, 23:77-85.
42. Sanz M.A., Grimwade D., Tallman M.S., et al. Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet. Blood 2009, 113:1875-1891.
43. Golub M.S., Macintosh M.S., Baumrind N. Developmental and reproductive toxicity of inorganic arsenic: animal studies and human concerns. J Toxicol Environ Health B Crit Rev 1998, 1:199-241.
44. Pye S.M., Cortes J., Ault P., et al. The effects of imatinib on pregnancy outcome. Blood 2008, 111:5505-5508.
45. Pacifici G.M., Nottoli R. Placental transfer of drugs administered to the mother. Clin Pharmacokinet 1995, 28:235-269.
46. Ault P., Kantarjian H., O'Brien S., et al. Pregnancy among patients with CML treated with imatinib. J Clin Oncol 2006, 24:1204-1208.
47. Prabash K., Sastry P.S., Biswas G., et al. Pregnancy outcome of two patients treated with imatinib. Ann Oncol 2005, 16:1983-1984.
48. Apperley J. CML in pregnancy and childhood. Best Pract Res Clin Haematol 2009, 22:455-474.
49. Ault P., Kantarjian H., O'Brien S., et al. Pregnancy among patients with chronic myeloid leukemia treated with imatinib. J Clin Oncol 2006, 24:1204-1208.
50. Rousselot P., Huguet F., Rea D., et al. Imatinib mesylate discontinuation in patients with chronic myelogenous leukemia in complete molecular remission for more than 2 years. Blood 2007, 109:58-60.
51. Burchert A., Muller M.C., Kostrewa P., et al. Sustained molecular response with interferon alfa maintenance after induction therapy with imatinib plus interferon alfa in patients with chronic myeloid leukemia. J Clin Oncol 2010, 28:1429-1435.